clarithromycin has been researched along with desvenlafaxine succinate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JY; Chung, MW; Ha, JH; Jiang, F; Kim, HD; Kim, YH; Lee, SY; Na, HS; Seo, DW; Shin, HJ | 1 |
1 trial(s) available for clarithromycin and desvenlafaxine succinate
Article | Year |
---|---|
The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.
Topics: Adult; Antidepressive Agents, Second-Generation; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Drug Interactions; Female; Genetic Markers; Genotype; Humans; Male; Metabolic Clearance Rate; Paroxetine; Phenotype; Premedication; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |